Journal Articles

Permanent URI for this collectionhttps://mro.massey.ac.nz/handle/10179/7915

Browse

Search Results

Now showing 1 - 3 of 3
  • Item
    The effect of prepartum synthetic zeolite supplementation on the eating, lying and activity behaviours of grazing dairy cows
    (Taylor and Francis Group on behalf of the Royal Society of New Zealand, 2024) Dalton JI; Hendriks SJ; Roche JR; Donaghy DJ; Dela Rue B; Kuhn-Sherlock B; Phyn CVC; Corner-Thomas R
    This study determined the effect of feeding synthetic zeolite A prepartum to reduce periparturient hypocalcaemia risk on the eating, lying, and activity behaviours of multiparous grazing dairy cows. Animals were randomly allocated to either a Zeolite treatment group (n = 21; individually fed 500 g/d zeolite for two weeks prepartum) or a Control group (n = 22). Behaviour data obtained from accelerometers were analysed to determine the effects of treatment, parity (Parity 2−3 vs. 4+), and their interactions during 3 periods: PRE (−21 to −3 d), PERI (−2–2 d) and POST (3–28 d) relative to the day of calving (day 0). Parity 2–3 Zeolite cows ate for 18 min/day less than Parity 2–3 Control cows PRE. Zeolite-fed cows also ate for 24 min/day less than Control cows during the PERI period. There were no treatment differences in lying time or activity PRE or PERI, but Zeolite-fed cows spent more time lying POST. Regardless of treatment, Parity 2–3 cows were generally more active and ate for longer than Parity 4 + cows. Our results suggest zeolite may subtly decrease appetite or alter eating behaviour during the supplementation period, particularly in younger cows, and may improve cow comfort postcalving.
  • Item
    Associations between peripartum lying and activity behaviour and blood non-esterified fatty acids and β-hydroxybutyrate in grazing dairy cows
    (Elsevier B.V. on behalf of The Animal Consortium, 2022-03) Hendriks SJ; Phyn CVC; Turner S-A; Mueller KR; Kuhn-Sherlock B; Donaghy DJ; Huzzey JM; Roche JR
    During early lactation, most dairy cows experience negative energy balance (NEB). Failure to cope with this NEB, however, can place cows at greater risk of developing metabolic disease. Our objective was to characterise, retrospectively, lying behaviour and activity of grazing dairy cows grouped according to blood non-esterified fatty acids (NEFAs) and β-hydroxybutyrate (BHB) as indicators of postpartum metabolic state. Blood was sampled weekly for up to 4 weeks precalving, on the day of calving (day 0), daily between 1 and 4 days postcalving, and then at least weekly between week 1 and week 5 postcalving for analysis of plasma NEFAs and BHB concentrations. Two hundred and forty-four multiparous Holstein-Friesian and Holstein-Friesian × Jersey cows were classified into one of three metabolic status groups based on maximum blood NEFAs and BHB concentrations during week 1 and 2 postcalving. A cow was classified as having either: (1) low NEFAs and low BHB (Lo–Lo; n = 78), when all blood samples were <1.0 mmol/L for NEFAs and ≤1.0 mmol/L for BHB during the first 2 weeks postcalving; (2) high NEFAs and low BHB (Hi–Lo; n = 134), when blood NEFAs were ≥1.0 mmol/L and blood BHB was ≤1.0 mmol/L at the same sampling time point during the first 2 weeks postcalving; or (3) high NEFAs and high BHB (Hi–Hi; n = 32), when blood NEFAs were ≥1.0 mmol/L and blood BHB was ≥1.2 mmol/L at the same sampling time point during the first 2 weeks postcalving. Accelerometers (IceTag or IceQube devices; IceRobotics Ltd.) were used to monitor lying and activity behaviours peripartum (–21 to +35 days relative to calving). Changes in lying behaviour and activity occurred before the mean day that cows were classified Hi–Hi and Hi–Lo (2.2 and 3.5 d postcalving, respectively). Up to 3 weeks preceding calving, Hi–Hi cows were more active, had fewer daily lying bouts (LBs), and spent less time lying than Lo–Lo cows. In addition, Hi–Hi cows had fewer daily LBs and were less active up to 4 weeks postcalving than Lo–Lo cows, but these differences were biologically small. Groups of grazing cows classified as experiencing a more severe metabolic challenge behave differently up to 3 weeks precalving than their herdmates with lower blood NEFAs and BHB postcalving. These altered behaviours may allow identification of individual cows at risk of a metabolic challenge, but further research is required.
  • Item
    Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview
    (BioMed Central Ltd, 10/07/2019) Ilesanmi-Oyelere BL; Schollum L; Kuhn-Sherlock B; McConnell M; Mros S; Coad J; Roy NC; Kruger MC
    Background: Cytokines, chemokines, C-reactive proteins (CRP) and ferritin are known inflammatory markers. However, cytokines such as interleukin (IL-1β), (IL-6) and tumour necrosis factor (TNF-α) have been reported to interfere with both the bone resorption and bone formation processes. Similarly, immune cell cytokines are known to contribute to inflammation of the adipose tissue especially with obesity. IL-10 but not IL-33 has been linked to lower ferritin levels and anemia. In this study, we hypothesized that specific cytokine levels in the plasma of women with low bone mineral density (BMD) would be higher than those in the plasma of healthy women due to the actions of elevated levels of pro-inflammatory cytokines in inducing osteoclast formation and differentiation during senescence. Results: Levels of cytokines (IFNα2, IFN-γ, IL-12p70, IL-33) and monocyte chemoattractant protein-1 (MCP-1) were significantly higher in the plasma of the osteoporotic group compared to the osteopenic and/or healthy groups. Meanwhile CRP levels were significantly lower in women with osteoporosis (P = 0.040) than the osteopenic and healthy groups. Hip BMD values were significantly lower in women with high/detectable values of IL-1β (P = 0.020) and IL-6 (P = 0.030) compared to women where these were not detected. Similarly, women with high/detectable values of IL-1β had significantly lower spine BMD than those where IL-1β was not detected (P = 0.030). Participants' CRP levels were significantly positively correlated with BMI, fat mass and fat percentage (P < 0.001). In addition, ferritin levels of women with high/detectable values of anti-osteoclastogenic IL-10 (P = 0.012) and IL-33 (P = 0.017) were significantly lower than those where these were not detected. There was no statistically significant association between TNF-α and BMD of the hip and lumbar spine. Conclusions: High levels of cytokines (IFNα2, IFN-γ, IL-12p70, IL-33) and MCP-1 in apparently healthy postmenopausal women are associated with bone health issues. In addition, an increase in levels of IL-10 and IL-33 may be associated with low ferritin levels in this age group. Trial registration: ANZCTR, ACTRN12617000802303. Registered May 31st, 2017, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373020.